An hour of moderate-intensity exercise reduced sensations of hunger in people with overweight and obesity in a recent study.

GLP-1 drugs mimic a hormone that sends the brain signals of fullness. Researchers theorize that the drugs could work the same ...

Looking for weight loss options? GLP-1 agonist medications, originally designed to manage type 2 diabetes, are now ...

The soaring demand for antidiabetic and weight-loss drugs has lured in many biotech and big Pharma companies. Onto this ...

New research suggests that Ozempic and similar weight loss medications have the potential to be as big a game changer in ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Studies have suggested that GLP-1RAs may show promise for a host of conditions, from alcohol use disorder to Parkinson’s. But ...

Oct. 17, 2024 — Researchers have developed strategies to identify regulators of intestinal hormone secretion. In response to incoming food, these hormones are secreted by rare hormone producing ...

GLP-1 stands for glucagon-like peptide-1, a hormone that plays a crucial role in regulating blood sugar levels. Ozempic was approved by the U.S. Food and Drug Administration (FDA) in 2017 for the ...

Explore how GLP-1 agonists, originally for diabetes, could transform addiction treatment by reducing cravings.

A RECENT population-based analysis has highlighted potential behavioural side effects associated with Glucagon-like peptide 1 ...